Provided by Tiger Trade Technology Pte. Ltd.

CVS Health

76.13
+0.06000.08%
Post-market: 76.250.1200+0.16%18:45 EDT
Volume:4.54M
Turnover:347.09M
Market Cap:96.64B
PE:54.77
High:77.17
Open:76.84
Low:76.03
Close:76.07
52wk High:85.15
52wk Low:58.35
Shares:1.27B
Float Shares:1.27B
Volume Ratio:0.67
T/O Rate:0.36%
Dividend:2.66
Dividend Rate:3.49%
EPS(TTM):1.39
EPS(LYR):1.39
ROE:2.29%
ROA:2.47%
PB:1.28
PE(LYR):54.77

Loading ...

CVS Group lifts revenue and expands in Australia as it joins LSE Main Market

TIPRANKS
·
Feb 26

Does Medicare Advantage Reimbursement Uncertainty Reshape The Bull Case For CVS Health’s Platform Strategy (CVS)?

Simply Wall St.
·
Feb 26

CVS Health Corp. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
Feb 26

BUZZ-U.S. STOCKS ON THE MOVE-Henry Schein, Domino's Pizza, FactSet

Reuters
·
Feb 24

CVS Health put volume heavy and directionally bearish

TIPRANKS
·
Feb 24

Analysts Offer Insights on Healthcare Companies: Gilead Sciences (GILD), Janux Therapeutics Inc (JANX) and CVS Health (CVS)

TIPRANKS
·
Feb 24

MEDIA-CVS employee bonuses surge after beating 2025 profit target - Bloomberg News

Reuters
·
Feb 24

Kelso CEO to Spotlight New Saga and CVS Stakes at Investor Event

TIPRANKS
·
Feb 20

CVS Pharmacy partners with USSF, National Women’s Soccer League

TIPRANKS
·
Feb 19

CVS Pharmacy Partners With U.S. Soccer Federation and National Women's Soccer League to Promote Community Health and Wellness

THOMSON REUTERS
·
Feb 19

CVS Health Announces $5 Million Scholarship Program to Support Future Pharmacists in Louisiana

THOMSON REUTERS
·
Feb 18

BRIEF-Mubadala Investment Co Pjsc Reports Share Stake In Pfizer, Abbvie, Dissolves in Merck, Dell

Reuters
·
Feb 18

CVS Health: Reaffirmed 2026 Guidance and Margin Restoration Drive Buy Rating Despite Near‑Term Headwinds

TIPRANKS
·
Feb 16

Did Earnings Beat, Record Sales and 2026 EPS Outlook Just Shift CVS Health's (CVS) Investment Narrative?

Simply Wall St.
·
Feb 15

Oppenheimer Keeps Their Hold Rating on CVS Health (CVS)

TIPRANKS
·
Feb 13

Goldman Sachs Adjusts Price Target on CVS Health to $97 From $95, Maintains Buy Rating

MT Newswires Live
·
Feb 12

Analysts See Multiple Growth Levers For CVS Health In 2026

Benzinga
·
Feb 12

Evercore ISI Sticks to Their Buy Rating for CVS Health (CVS)

TIPRANKS
·
Feb 11

BUZZ-Street View: CVS powers its turnaround score amid Medicare pressure

Reuters
·
Feb 11

Humana Loss Was Less Than Expected. Why the Stock Is Falling. -- Barrons.com

Dow Jones
·
Feb 11